HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

CpG ODN-OVA

a specific CpG ODN conjugated to ovalbumin; putative oral vaccine; base sequence of the CpG ODN given in first source

Also Known As:

CpG ODN-ovalbumin

Networked: 3 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Kita, Toshiyuki: 1 article (01/2015)
2.	Kitamura, Hidemitsu: 1 article (01/2015)
3.	Masuko, Kazutaka: 1 article (01/2015)
4.	Nishimura, Takashi: 1 article (01/2015)
5.	Togashi, Yuji: 1 article (01/2015)
6.	Wakita, Daiko: 1 article (01/2015)
7.	Akiyama, Hiroshi: 1 article (03/2006)
8.	Maitani, Tamio: 1 article (03/2006)
9.	Okunuki, Haruyo: 1 article (03/2006)
10.	Sato, Yuji: 1 article (03/2006)

Related Diseases

1.	Weight Gain 12/13/2022 - "Mice with the ε-PLL/G4-CpG ODN/ovalbumin (OVA) complex showed increased OVA-specific immunoglobulin (Ig)G, IgG1, and IgG2c levels, whereas total IgE levels did not increase and weight gain rates were not affected. "
2.	Neoplasms (Cancer) 01/01/2015 - "In combination with adjuvant CpG-ODN, OVA-H/KHELP exhibited greater vaccine efficacy compared with short peptides vaccine, in both preventive and therapeutic vaccine models against OVA-expressing EG-7 tumor. "
3.	Hypersensitivity (Allergy) 03/01/2006 - "These results indicated that oral administration of CpG ODN-OVA conjugate significantly induced antigen-specific Th1 responses and reduced Th2 responses (allergic reactions) on re-stimulation. "

Related Drugs and Biologics

1.	Vaccines
2.	Peptides (Polypeptides)
3.	Immunoglobulins (Immunoglobulin)
4.	Immunoglobulin G (IgG)
5.	Immunoglobulin E (IgE)
6.	Antigens

Related Therapies and Procedures

1.	Oral Administration